ATE173726T1 - 3-hydroxypyridin-4-on-derivate als chelatbildner - Google Patents
3-hydroxypyridin-4-on-derivate als chelatbildnerInfo
- Publication number
- ATE173726T1 ATE173726T1 AT93910215T AT93910215T ATE173726T1 AT E173726 T1 ATE173726 T1 AT E173726T1 AT 93910215 T AT93910215 T AT 93910215T AT 93910215 T AT93910215 T AT 93910215T AT E173726 T1 ATE173726 T1 AT E173726T1
- Authority
- AT
- Austria
- Prior art keywords
- ethyl
- pct
- methylpropionyloxy
- alpha
- group
- Prior art date
Links
- LQUSVSANJKHVTM-UHFFFAOYSA-N 3-hydroxy-3h-pyridin-4-one Chemical class OC1C=NC=CC1=O LQUSVSANJKHVTM-UHFFFAOYSA-N 0.000 title 1
- 239000002738 chelating agent Substances 0.000 title 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 4
- -1 2-pivaloyloxyethyl groups Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 231100000816 toxic dose Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929217099A GB9217099D0 (en) | 1992-08-12 | 1992-08-12 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE173726T1 true ATE173726T1 (de) | 1998-12-15 |
Family
ID=10720221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93910215T ATE173726T1 (de) | 1992-08-12 | 1993-05-18 | 3-hydroxypyridin-4-on-derivate als chelatbildner |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5480894A (de) |
| EP (1) | EP0619808B1 (de) |
| JP (1) | JPH07500120A (de) |
| AT (1) | ATE173726T1 (de) |
| CA (1) | CA2119020C (de) |
| DE (1) | DE69322250T2 (de) |
| ES (1) | ES2124307T3 (de) |
| GB (2) | GB9217099D0 (de) |
| WO (1) | WO1994004498A1 (de) |
| ZA (1) | ZA935084B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0833627B1 (de) | 1995-06-10 | 2004-08-18 | Vitra Pharmaceuticals Ltd. | Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon |
| ES2244967T3 (es) * | 1995-09-29 | 2005-12-16 | Novartis Ag | Nuevas hidroxipiridinonas. |
| US6767741B1 (en) * | 1999-08-27 | 2004-07-27 | Invitrogen Corporation | Metal binding compounds and their use in cell culture medium compositions |
| IL135884A (en) * | 2000-04-30 | 2005-08-31 | Yissum Res Dev Co | Method for measuring non-transferrin bound iron |
| AU2001287850A1 (en) | 2000-09-19 | 2002-04-02 | Vitra Pharmaceuticals Limited | Iron compositions |
| CN100515928C (zh) * | 2000-12-22 | 2009-07-22 | 空气制品及化学品有限公司 | 包含氧化和络合化合物的组合物 |
| US6426418B1 (en) | 2001-11-02 | 2002-07-30 | Apotex, Inc. | Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide |
| PL371746A1 (en) | 2002-02-05 | 2005-06-27 | Bristol-Myers Squibb Company | N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| GB0211500D0 (en) | 2002-05-18 | 2002-06-26 | Vitra Pharmaceuticals Ltd | Method of forming iron hydroxypyrone compounds |
| CA2504512A1 (en) | 2002-10-30 | 2004-05-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Molecules and methods using same for measuring non-transferrin bound iron |
| US7707255B2 (en) | 2003-07-01 | 2010-04-27 | Microsoft Corporation | Automatic grouping of electronic mail |
| NZ529657A (en) | 2003-11-20 | 2004-07-30 | Apotex Inc | Iron chelating cycloalkyl derivatives of 3-hydroxy-4-pyridinones |
| CA2488034C (en) * | 2004-11-19 | 2009-10-06 | Apotex Inc. | Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues |
| US9588781B2 (en) | 2008-03-31 | 2017-03-07 | Microsoft Technology Licensing, Llc | Associating command surfaces with multiple active components |
| GB201007209D0 (en) | 2010-04-29 | 2010-06-16 | King S College London | Compound |
| WO2012137202A1 (en) | 2011-04-05 | 2012-10-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci) |
| DE102012007558A1 (de) | 2012-04-14 | 2013-10-17 | Alf Hammes | Gabe substituierter bis-aryl-harnstoffderivate zur behandlung von anämien |
| GB201215675D0 (en) | 2012-09-03 | 2012-10-17 | Univ Exeter | Compound |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1074038B (it) * | 1976-08-05 | 1985-04-17 | Simes | Esteri della epinina |
| GB8308055D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| GB8308054D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| EP0305646B1 (de) * | 1983-03-24 | 1996-11-13 | Btg International Limited | 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen |
| US4908371A (en) * | 1987-11-10 | 1990-03-13 | Ciba-Geigy Corporation | Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload |
| WO1989009211A1 (en) * | 1988-03-31 | 1989-10-05 | The Royal Free Hospital School Of Medicine | Process for producing pyrid-4-ones |
| GB8910521D0 (en) * | 1989-05-08 | 1989-06-21 | Nat Res Dev | The stabilization of organic compounds |
| GB9100465D0 (en) * | 1991-01-09 | 1991-02-20 | Hider Robert C | Pharmaceutical compositions |
| GB9209078D0 (en) * | 1992-04-27 | 1992-06-10 | Hider Robert C | Pharmaceutical compositions |
-
1992
- 1992-08-12 GB GB929217099A patent/GB9217099D0/en active Pending
-
1993
- 1993-05-18 WO PCT/GB1993/001007 patent/WO1994004498A1/en not_active Ceased
- 1993-05-18 JP JP6505976A patent/JPH07500120A/ja active Pending
- 1993-05-18 US US08/204,202 patent/US5480894A/en not_active Expired - Fee Related
- 1993-05-18 ES ES93910215T patent/ES2124307T3/es not_active Expired - Lifetime
- 1993-05-18 CA CA002119020A patent/CA2119020C/en not_active Expired - Fee Related
- 1993-05-18 DE DE69322250T patent/DE69322250T2/de not_active Expired - Fee Related
- 1993-05-18 AT AT93910215T patent/ATE173726T1/de not_active IP Right Cessation
- 1993-05-18 EP EP93910215A patent/EP0619808B1/de not_active Expired - Lifetime
- 1993-07-01 GB GB9313557A patent/GB2269589B/en not_active Revoked
- 1993-07-14 ZA ZA935084A patent/ZA935084B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9313557D0 (en) | 1993-08-18 |
| GB9217099D0 (en) | 1992-09-23 |
| CA2119020C (en) | 2003-12-16 |
| ES2124307T3 (es) | 1999-02-01 |
| JPH07500120A (ja) | 1995-01-05 |
| CA2119020A1 (en) | 1994-03-03 |
| DE69322250D1 (de) | 1999-01-07 |
| GB2269589B (en) | 1996-06-26 |
| US5480894A (en) | 1996-01-02 |
| DE69322250T2 (de) | 1999-05-20 |
| GB2269589A (en) | 1994-02-16 |
| EP0619808B1 (de) | 1998-11-25 |
| WO1994004498A1 (en) | 1994-03-03 |
| EP0619808A1 (de) | 1994-10-19 |
| ZA935084B (en) | 1995-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE173726T1 (de) | 3-hydroxypyridin-4-on-derivate als chelatbildner | |
| DE59106756D1 (de) | Neuartige Antiepileptika. | |
| KR960701051A (ko) | 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases) | |
| ATE184008T1 (de) | Pyrrolopyridinderivate als dopaminrezeptor liganden | |
| ES2062558T3 (es) | Compuestos contra el cancer. | |
| ES2098947T3 (es) | Derivados de beta,beta-dimetil-4-piperidinoetanamina como inhibidores de la biosintesis del colesterol. | |
| GB9305641D0 (en) | Therapeutic agents | |
| DK0632805T3 (da) | Melaminderivater til anvendelse i behandlingen af cancer | |
| DE69129272D1 (de) | Dextrinsulfate als anti hiv-1 wirkstoffe und diese enthaltende zubereitungen | |
| FI934680A0 (fi) | Arylmorfolin, framstaellning och anvaending | |
| IT1196423B (it) | Benzotiazolin-composti | |
| CS9100438A2 (en) | New derivative of beta-phenylisoserine, method of its preparation and its application | |
| HUT65978A (en) | Pharmaceutical compositions applicable for treatment of enteropathia and containing imidazol-1-yl-compounds | |
| DE69413831D1 (de) | Phenoxyphenylcyclopentenyl-hydroxyharnstoffe | |
| ATE141153T1 (de) | Allylamino-nitroaromaten | |
| GR3025050T3 (en) | Etoposide derivatives, process for their preparation, their use as a drug and in the preparation of a drug for treating cancer. | |
| ATE147755T1 (de) | Dipeptidderivate und diese als aktive bestandteile enthaltendes prophylaktisches oder therapeutisches mittel gegen knochenkrankheiten | |
| SE9603284D0 (sv) | New compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |